Compensation award — excluded from discretionary-purchase analysis.
Loading…
Traded Dec 17, 2025 · Filed Dec 19, 2025
A board member of Repligen sold $44K of Repligen shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$44,275
Shares × reported transaction price
50 days after results of Oct 28, 2025, 69 days before results of Feb 24, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +2.4% | +1.4% | +0.9% |
| 30 days | +0.6% | −0.4% | +1.0% |
| 90 days | −27.6% | −3.0% | −24.5% |
| 180 days | −17.8% | +8.9% | −26.6% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Derivative exercise or conversion — not an open-market buy.